Cis target KEGG enrichment (Fig. 5a) mainly clustered in several cancers and carcinomas, vascular smooth muscle contraction and focal adhesion, while the trans target KEGG (Additional file 3)A were enriched in the p53 signaling pathway, lysosome and ubiquinone and other terpenoid-quinone biosynthesis. The gene discussed is TP53; the disease is cancer.